Title:
ADJUVANT AND TRANSMUCOSAL VACCINE
Document Type and Number:
WIPO Patent Application WO/2024/071368
Kind Code:
A1
Abstract:
The present invention provides an adjuvant and a transmucosal vaccine that are highly capable of inducing secretory IgA in addition to serum IgA and IgG when transmucosally administered. The invention relates to the adjuvant that comprises, as an active ingredient, one or more polypeptides selected from: (1) a polypeptide having at least one or two amino acid sequences represented by SEQ ID NO: 1; and (2) a polypeptide having 93% or more identity with the aforesaid amino acid sequence.
Inventors:
SASAKI HIRAKU (JP)
SUZUKI YOSHIO (JP)
ISHIKAWA HIROKI (JP)
SUZUKI YOSHIO (JP)
ISHIKAWA HIROKI (JP)
Application Number:
PCT/JP2023/035586
Publication Date:
April 04, 2024
Filing Date:
September 29, 2023
Export Citation:
Assignee:
JUNTENDO EDUCATIONAL FOUND (JP)
International Classes:
A61K39/39; A61K39/08; A61K39/10; A61K39/145; A61K39/165; A61K39/215; A61K39/23; A61P31/04; A61P31/14; A61P31/16; A61P31/20; A61P37/04; A61P43/00; C07K14/285
Attorney, Agent or Firm:
ARUGA PATENT OFFICE (JP)
Download PDF:
Previous Patent: COMPOSITION FOR ENHANCING EFFECT OF ACTIVE SUBSTANCE
Next Patent: PROGRAM, PROCESSING DEVICE, AND PROCESSING METHOD
Next Patent: PROGRAM, PROCESSING DEVICE, AND PROCESSING METHOD